(Q37964270)

26 August 2017

title

Histology and proteinuria after renal transplantation (English)

1 reference

26 August 2017

Daniel Serón

1

1 reference

26 August 2017

Dolores Burgos

series ordinal

2

1 reference

26 August 2017

Angel Alonso

series ordinal

3

1 reference

26 August 2017

publication date

1 January 2012

1 reference

26 August 2017

published in

Transplantation Reviews

1 reference

26 August 2017

volume

26

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

20-26

1 reference

Late renal allograft failure between 1990 and 1998 in Spain: a changing scenario

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Significance and management of proteinuria in kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

The clinical significance of early proteinuria after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Early protocol renal allograft biopsies and graft outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

The natural history of chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Identifying specific causes of kidney allograft loss.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Proteinuria after kidney transplantation, relationship to allograft histology and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Transplant glomerulopathy: morphology, associations and mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Baseline immunosuppression is associated with histological findings in early protocol biopsies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Risk of renal allograft loss from recurrent glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Recurrent glomerulonephritis after kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Rituximab in idiopathic membranous nephropathy: a one-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Antithymocyte globulin (ATG) induction therapy and disease recurrence in renal transplant recipients with primary IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Calcineurin inhibitor nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

mToR inhibitors-induced proteinuria: mechanisms, significance, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Sirolimus interacts with pathways essential for podocyte integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

Sirolimus and proteinuria in renal transplant patients: evidence for a dose-dependent effect on slit diaphragm-associated proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2011.07.009

10.1016/J.TRRE.2011.07.009

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference